ID   SH-SY5Y-pCEP4-ra7
AC   CVCL_F0ST
SY   SH-SY5Y-pCEP4-ralpha7
RX   PubMed=15590768;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2348; Chrna7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=15590768; DOI=10.1124/jpet.104.079004;
RA   Peng, Jian-Hong
RA   Fryer, John D.
RA   Hurst, Raymond S.
RA   Schroeder, Katherine Marie
RA   George, Andrew A.
RA   Morrissy, Steven
RA   Groppi, Vincent E.
RA   Leonard, Sherry S.
RA   Lukas, Ronald John
RT   "High-affinity epibatidine binding of functional, human
RT   alpha7-nicotinic acetylcholine receptors stably and heterologously
RT   expressed de novo in human SH-EP1 cells.";
RL   J. Pharmacol. Exp. Ther. 313:24-35(2005).
//